SF
ABMD

Synovus Financial’s Abiomed Inc ABMD Stock Holding History

Synovus Financial’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-132
Closed -$32K – 1551
2020
Q2 		$32K Sell
132
-80
-38% -$16.1K ﹤0.01% 999
2020
Q1 		$30K Buy
212
+80
+61% +$13.3K ﹤0.01% 1253
2019
Q4 		$22K Hold
132
– – ﹤0.01% 1101
2019
Q3 		$22K Hold
132
– – ﹤0.01% 1075
2019
Q2 		$35K Hold
132
– – ﹤0.01% 907
2019
Q1 		$37K Hold
132
– – ﹤0.01% 885
2018
Q4 		$43K Hold
132
– – ﹤0.01% 824
2018
Q3 		$60K Buy
132
+48
+57% +$18.9K ﹤0.01% 795
2018
Q2 		$34K Hold
84
– – ﹤0.01% 858
2018
Q1 		$24K Buy
+84
New +$21.3K ﹤0.01% 908

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Synovus Financial's ABMD Position: Q3 2020 in Review

Synovus Financial sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 132 shares — an estimated $32K sold.

Synovus Financial first reported a position in ABMD in Q1 2018 and held it in 10 quarters. The position peaked at $60K in Q3 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • Synovus Financial reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 132 Abiomed Inc shares in Q3 2020, an estimated $32K.
  • Synovus Financial first reported a position in Abiomed Inc in Q1 2018 and held it in 10 quarters.
  • Synovus Financial's Abiomed Inc position peaked at $60K in Q3 2018.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.